SUN-675 Breast Cancer Treatment Causes Diabetes

Introduction: Alpelisib (BYL719) a PI3K p110alpha inhibitor, was recently FDA approved to treat postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA gene mutation positive, advanced or metastatic breast cancer following progressio...

Full description

Saved in:
Bibliographic Details
Published in:J Endocr Soc
Main Authors: Silparshetty, Santh V S, Bhatt, Bankim
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Diabetes Mellitus and Glucose Metabolism
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7209164/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1965
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items